726 related articles for article (PubMed ID: 23189968)
1. Impact of thyroid dysfunction on erythropoietin dosage in hemodialysis patients.
Ng YY; Lin HD; Wu SC; Yang CY; Yang WC; Liou HH; Hu FH; Hou CC; Tseng SS; Ku NY; Hsiao NY; Wu WC; Tu HM; Lien TJ; Lee CC; Tsang KK; Cheng CS; Hu J; Lin RP
Thyroid; 2013 May; 23(5):552-61. PubMed ID: 23189968
[TBL] [Abstract][Full Text] [Related]
2. Thyroid function, cardiovascular events, and mortality in diabetic hemodialysis patients.
Drechsler C; Schneider A; Gutjahr-Lengsfeld L; Kroiss M; Carrero JJ; Krane V; Allolio B; Wanner C; Fassnacht M
Am J Kidney Dis; 2014 Jun; 63(6):988-96. PubMed ID: 24315768
[TBL] [Abstract][Full Text] [Related]
3. Effect of thyroid function status in hemodialysis patients on erythropoietin resistance and interdialytic weight gain.
Bin Saleh FS; Naji MN; Eltayeb AA; Hejaili FF; Al Sayyari AA
Saudi J Kidney Dis Transpl; 2018; 29(6):1274-1279. PubMed ID: 30588957
[TBL] [Abstract][Full Text] [Related]
4. Thyroid function and cardiovascular events in chronic kidney disease patients.
Afsar B; Yilmaz MI; Siriopol D; Unal HU; Saglam M; Karaman M; Gezer M; Sonmez A; Eyileten T; Aydin I; Hamcan S; Oguz Y; Covic A; Kanbay M
J Nephrol; 2017 Apr; 30(2):235-242. PubMed ID: 27039198
[TBL] [Abstract][Full Text] [Related]
5. The effect of subclinic thyroid pathologies on erythropoietine dose in hemodialysis patients.
Onan E; Yasar M; Soysal B; Paydas S
Ther Apher Dial; 2023 Jun; 27(3):587-592. PubMed ID: 36504443
[TBL] [Abstract][Full Text] [Related]
6. Prevalence of clinical and subclinical thyroid disease in a peritoneal dialysis population.
Ng YY; Wu SC; Lin HD; Hu FH; Hou CC; Chou YY; Chiu SM; Sun YH; Cho SS; Yang WC
Perit Dial Int; 2012; 32(1):86-93. PubMed ID: 21532003
[TBL] [Abstract][Full Text] [Related]
7. Prognostic impact of subclinical thyroid dysfunction in heart failure.
Frey A; Kroiss M; Berliner D; Seifert M; Allolio B; Güder G; Ertl G; Angermann CE; Störk S; Fassnacht M
Int J Cardiol; 2013 Sep; 168(1):300-5. PubMed ID: 23041000
[TBL] [Abstract][Full Text] [Related]
8. Relationship between insulin resistance and erythropoietin responsiveness in hemodialysis patients.
Abe M; Okada K; Soma M; Matsumoto K
Clin Nephrol; 2011 Jan; 75(1):49-58. PubMed ID: 21176750
[TBL] [Abstract][Full Text] [Related]
9. 2008 Japanese Society for Dialysis Therapy: guidelines for renal anemia in chronic kidney disease.
Tsubakihara Y; Nishi S; Akiba T; Hirakata H; Iseki K; Kubota M; Kuriyama S; Komatsu Y; Suzuki M; Nakai S; Hattori M; Babazono T; Hiramatsu M; Yamamoto H; Bessho M; Akizawa T
Ther Apher Dial; 2010 Jun; 14(3):240-75. PubMed ID: 20609178
[TBL] [Abstract][Full Text] [Related]
10. Clinical efficacy of recombinant human erythropoietin in the treatment of anemia in hemodialysis patients: influence of dosing regimen, iron status, and serum aluminum.
Tsai JC; Lai YH; Tsai ZY; Chien LJ; Tsai JH
Gaoxiong Yi Xue Ke Xue Za Zhi; 1991 Mar; 7(3):126-35. PubMed ID: 1865507
[TBL] [Abstract][Full Text] [Related]
11. The efficacy of darbepoetin alpha in hemodialysis patients resistant to human recombinant erythropoietin (rHuEpo).
Hejaili F
Saudi J Kidney Dis Transpl; 2009 Jul; 20(4):590-5. PubMed ID: 19587498
[TBL] [Abstract][Full Text] [Related]
12. Relationship between protein-energy wasting in adults with chronic hemodialysis and the response to treatment with erythropoietin.
González-Ortiz A; Correa-Rotter R; Vázquez-Rangel A; Vega-Vega O; Espinosa-Cuevas Á
BMC Nephrol; 2019 Aug; 20(1):316. PubMed ID: 31412807
[TBL] [Abstract][Full Text] [Related]
13. [Recombinant human erythropoietin: 18 months of continuous use in substitution hemodialysis].
Canaud B; Polito-Bouloux C; Rivory JP; Donnadieu P; Taib J; Florence P; Mion C
Nephrologie; 1990; 11(1):5-10. PubMed ID: 2374643
[TBL] [Abstract][Full Text] [Related]
14. Recombinant human erythropoietin independence in chronic hemodialysis patients: clinical features, iron homeostasis and erythropoiesis.
Kuo CC; Lee CT; Chuang CH; Su Y; Chen JB
Clin Nephrol; 2005 Feb; 63(2):92-7. PubMed ID: 15730050
[TBL] [Abstract][Full Text] [Related]
15. Subclinical thyroid dysfunction and blood pressure: a community-based study.
Walsh JP; Bremner AP; Bulsara MK; O'Leary P; Leedman PJ; Feddema P; Michelangeli V
Clin Endocrinol (Oxf); 2006 Oct; 65(4):486-91. PubMed ID: 16984241
[TBL] [Abstract][Full Text] [Related]
16. Subclinical hypothyroidism is associated with coronary artery disease in older persons.
Mya MM; Aronow WS
J Gerontol A Biol Sci Med Sci; 2002 Oct; 57(10):M658-9. PubMed ID: 12242320
[TBL] [Abstract][Full Text] [Related]
17. [Thyroid dysfunction in children with chronic renal failure].
Garrido-Magaña E; Heyser-Ortiz SE; Aguilar-Kitsu A; Mendoza-Guevara L; Ramirez-Rivera A; Nishimura-Meguro E; García HJ; Villasís-Keever MA
Nefrologia; 2009; 29(5):449-55. PubMed ID: 19820757
[TBL] [Abstract][Full Text] [Related]
18. Relationship between erythropoietin responsiveness, insulin resistance, and malnutrition-inflammation-atherosclerosis (MIA) syndrome in hemodialysis patients with diabetes.
Abe M; Okada K; Maruyama T; Maruyama N; Matsumoto K; Soma M
Int J Artif Organs; 2011 Jan; 34(1):16-25. PubMed ID: 21298620
[TBL] [Abstract][Full Text] [Related]
19. [Thyroid dysfunction in adults infected by human immunodeficiency virus].
Abelleira E; De Cross GA; Pitoia F
Medicina (B Aires); 2014; 74(4):315-20. PubMed ID: 25188661
[TBL] [Abstract][Full Text] [Related]
20. Non-autoimmune primary hypothyroidism in diabetic and non-diabetic chronic renal dysfunction.
Bando Y; Ushiogi Y; Okafuji K; Toya D; Tanaka N; Miura S
Exp Clin Endocrinol Diabetes; 2002 Nov; 110(8):408-15. PubMed ID: 12518252
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
